Session Details

Moderator

Rohini K. Bhatia, Emory University, Winship Cancer Institute, Atlanta, GA

Moderator

Roshni Rao, Columbia University Medical Center, New York, NY

Presentation numberRF6-1

Interim event-free survival with peri-operative immune checkpoint inhibition and cryoablation in residual triple-negative breast cancer

Heather L McArthur, UTSW, Dallas, TX

Presentation numberRF6-2

Breast-mri trial: the paradox of preoperative breast mri — more surgery, no detectable survival benefit in a randomized trial

Bruna S Mota, ICESP, Sao Paulo, Brazil

Presentation numberRF6-3

Technical outcomes of node marking and targeted axillary dissection after neoadjuvant chemotherapy in node-positive breast cancer: results from 1295 participants in the ATNEC trial

Amit Goyal, Royal Derby Hospital, Derby, United Kingdom

Presentation numberRF6-4

Prediction of pathological tumor size in 2,138 breast cancer patients treated with breast-conserving surgery: comparative analysis of preoperative imaging modalities in the prospective multicenter MELODY (EUBREAST-4 / iBRA-NET / AGO-B-062) study

Nikolas Tauber, University of Luebeck, Luebeck, Germany

Presentation numberRF6-5

Axillary Radiotherapy as an Alternative to Axillary Lymph Node Dissection in Sentinel Node-Positive Breast CancerPatientsAfter Neoadjuvant Therapy: Three-Year Outcomes from the ADARNAT Pilot Randomized Trial

Amparo Garcia-Tejedor, Bellvitge Hospital, L'Hospitalet de Llobregat, Spain

Presentation numberRF6-6

One-week or three-week Adjuvant Radiation in Breast Cancer (OTHAR) – A Phase III Non-Inferiority Randomized controlled Trial- Early outcomes and Acute Toxicity Results

Supriya Mallick, National Cancer Institute-All India Institute of Medical Sciences,New Delhi, New Delhi, India

Presentation numberRF6-7

Oncological safety of breast-conserving surgery following neo-adjuvant chemotherapy in locally advanced breast cancer: Results from a randomized controlled trial

Ankita Manan Sheth, Tata Memorial Hospital, Mumbai, India